Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Microsatellite instability in gastrointestinal cancers

European Journal of Human Genetics (2022)Cite this article

Subjects

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Velho S, Corso G, Oliveíra C, Seruca R. KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers. Adv Cancer Res. 2010;109:123–43.

    CAS  Article  Google Scholar 

  2. Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, et al. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer. 2011;128:1606–13.

    CAS  Article  Google Scholar 

  3. Corso G, Pedrazzani C, Marrelli D, Pascale V, Pinto E, Roviello F. Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg. 2009;144:722–7.

    CAS  Article  Google Scholar 

  4. Corso G, Pascale V, Flauti G, Ferrara F, Marrelli D, Roviello F. Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients. Eur J Hum Genet. 2013;21:1383–8.

    CAS  Article  Google Scholar 

  5. Berardinelli GN, Durães R, Mafra da Costa A, Bragagnoli A, Antônio de Oliveira M, Pereira R, et al. Association of microsatellite instability (MSI) status with the 5-year outcome and genetic ancestry in a large Brazilian cohort of colorectal cancer. Eur J Hum Genet. 2022. in press

  6. Latham A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D, et al. Microsatellite instability is associated with the presence of lynch syndrome pan-cancer. J Clin Oncol. 2019;37:286–95.

    CAS  Article  Google Scholar 

  7. Pedrazzani C, Corso G, Velho S, Leite M, Pascale V, Bettarini F, et al. Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer. 2009;8:215–20.

    CAS  Article  Google Scholar 

  8. Diaz LA Jr., Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23:659–70.

    Article  Google Scholar 

  9. Muro K, Chung HC, Shankaran V, Geva R, Catenacci D, Gupta S, et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol. 2016;17:717–26.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The preparation of this study was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 ×1000 funds.

Author information

Authors and Affiliations

  1. Division of Breast Surgery, European Institute of Oncology (IEO), IRCCS, Milan, 20141, Italy

    Giovanni Corso

  2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, 20122, Italy

    Giovanni Corso

  3. European Cancer Prevention Organization (ECP), Milan, 20141, Italy

    Giovanni Corso

Authors
  1. Giovanni Corso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Corso.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Corso, G. Microsatellite instability in gastrointestinal cancers. Eur J Hum Genet (2022). https://doi.org/10.1038/s41431-022-01134-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41431-022-01134-6

Search

Advanced search

Quick links